Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Biological Chemistry|June 3, 2023
Efficient chimeric antigen receptor targeting of a central epitope of CD22Nicholas Paul Casey, Clara Helena Klee, Anne Fåne, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2013
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastomaEinar Osland Vik-Mo, Marta Nyakas, Birthe Viftrup Mikkelsen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 7, 2026
Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability PerspectivesErica Frostegård, Tatiana Bobrova, Amalie Leinebø, et al.
Leukemia|April 4, 2025
LILRB1-directed CAR-T cells for the treatment of hematological malignanciesKatsiaryna Marhelava, Klaudyna Fidyt, Monika Pepek, et al.
Cell Reports. Medicine|May 16, 2024
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemiaBenjamin Caulier, Sandy Joaquina, Pascal Gelebart, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16Nicholas P Casey, Katrin Kleinmanns, Christopher Forcados, et al.
Cell Reports. Medicine|September 9, 2025
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumorsRafaela Abrantes, Christopher Forcados, David J Warren, et al.
Oncoimmunology|June 7, 2024
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapiesMalgorzata Bobrowicz, Aleksandra Kusowska, Marta Krawczyk, et al.
Nature Communications|June 8, 2023
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcomaNadia Mensali, Hakan Köksal, Sandy Joaquina, et al.
Pageof 6